
From Ethics to Evidence: Applying Real-World Data in Oncology Trials


From Ethics to Evidence: Applying Real-World Data in Oncology Trials
June 23 @ 1:00 pm – 2:00 pm
As part of Oncology Research Pulse, our new thought leadership initiative designed to foster collaboration that advances oncology research, we’re partnering with Fierce Pharma to explore how to ethically and effectively incorporate RWD into oncology clinical research.
Real-world data (RWD) is a powerful asset for pharmaceutical sponsors looking to enhance oncology trial design, support regulatory submissions, and demonstrate real-world value. From generating external control arms to identifying patient cohorts and uncovering long-term safety signals, RWD offers strategic advantages across the development lifecycle. But as the stakes grow, so does the ethical responsibility to use RWD with transparency, fairness, and patient-centered rigor.
This webinar will explore how to ethically and effectively incorporate RWD into oncology clinical research. Industry leaders and experts will share insights on navigating consent, bias, and data provenance—while aligning with regulatory expectations and building confidence in research practices.
Key Takeaways
- How RWD can be used to improve oncology clinical trial design and operations
- Ethical considerations around patient privacy, informed consent, and data provenance—and strategies to align scientific, ethical, and reputational goals in trial design
- FDA, EMA, and global guidance on the responsible use of RWD
- Designed for R&D, clinical strategy, and regulatory leaders, this session offers a practical framework for building responsible, high-impact RWD programs in oncology research.
Featured Speakers

Ashita Batavia, MD, MS
Head of Hematology & Oncology Data Sciences, R&D
Johnson & Johnson

Amit Raval, PhD
Global Director of Real-World Evidence
Bayer

André Mansinho, MD
Director, Clinical Research
The START Center for Cancer Care

James Riddle
MCSE, CIP, CPIA, CRQMSenior Vice President, Global Review Operations, Advarra